ResearchMoz presents this most up-to-date research on “Diagnostic Procedures For Prenatal and New-born Genetic Testing Global Market (PCR, FISH, aCGH, NIPT and MSS) During The Period 2017 – 2019”.

Prenatal testing and diagnosis have enabled the detection of certain genetic abnormalities in as early as 8 to 10 weeks of gestation and also helps to determine the sex of the fetus. Prenatal and newborn genetic testing is referred to as the utilization of screening/diagnostic procedures for a fetus or a new born baby to detect chromosomal abnormalities such as Down syndrome, Patau syndrome and Edward syndrome. This report studies the global prenatal and newborn genetic testing market from two perspectives namely, types of technologies and the major geographic markets. The global prenatal and newborn genetic testing market by technology has been segmented as diagnostic technique and screening methods. Diagnostic technique is further classified as polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH) and array-comparative genomic hybridization (aCGH). Similarly, screening methods are further categorized as non-invasive prenatal tests and maternal serum screening.

Geographically, the report segments the global prenatal and newborn genetic testing market into four main regions namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market sizes and forecasts for the period 2011 to 2019 in terms of revenue (USD million), considering 2012 as the base year, have been provided for each technology type and geographic region, along with their sub-segments (if any). The prenatal and newborn genetic testing market report also provides compounded annual growth rate (CAGR %) during the forecast period 2013 to 2019 for all the aforementioned segments.

The market overview section of the prenatal and newborn genetic testing market report discusses the market dynamics with respect to market drivers, restraints and opportunities. This section also covers market attractiveness analysis (by geography) and Porter’s five forces analysis for the global prenatal and newborn genetic testing market. Market share (%) for the major players operating in prenatal and newborn genetic testing market has also been provided for the year 2012, followed by a list of recommendations for the existing and new players to enter and enhance their market shares. The report concludes with the company profiles of key players operating in various segments of prenatal and newborn genetic testing market. Each company profile includes the business overview, financial overview, product portfolio, business strategies and recent developments of the respective company.

Some of the prominent players in the prenatal and newborn genetic testing market that have been profiled in this report include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Natera, Inc. and Illumina, Inc.